Kb Financial Partners, LLC Bio Techne Corp Transaction History

Kb Financial Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 17, 2023	BUY	$80.67 - $352.29 $56,388 - $246,250	699 Added 394.92%	876 $73,000
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $7,628 - $10,579	-27 Reduced 13.24%	177 $50,000
Q2 2022 Aug 11, 2022	SELL	$322.67 - $449.65 $968 - $1,348	-3 Reduced 1.45%	204 $71,000
Q1 2022 May 17, 2022	BUY	$353.85 - $487.79 $6,015 - $8,292	17 Added 8.95%	207 $90,000
Q4 2021 Feb 18, 2022	BUY	$456.15 - $525.06 $86,668 - $99,761	190 New	190 $98,000
Q3 2021 Nov 16, 2021	SELL	$444.87 - $538.88 $40,928 - $49,576	-92 Closed	0 $0
Q2 2021 Aug 17, 2021	SELL	$387.35 - $450.26 $7,747 - $9,005	-20 Reduced 17.86%	92 $41,000
Q1 2021 Jun 08, 2021	BUY	$314.62 - $411.0 $35,237 - $46,032	112 New	112 $43,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.96B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Kb Financial Partners, LLC with notifications on news.